Tissue factor produced by the endocrine cells of the islets of langerhans is associated with a negative outcome of clinical islet transplantation

Diabetes

Volumn 54, Issue 6, 2005, Pages 1755-1762

  Johansson, Helena ^a   Lukinius, Agneta ^a   Moberg, Lisa ^a   Lundgren, Torbjörn ^b   Berne, Christian ^a   Foss, Aksel ^c   Felldin, Marie ^d   Källen, Ragnar ^e   Salmela, Kaija ^f   Tibell, Annika ^b   Tufveson, Gunnar ^a   Ekdahl, Kristina Nilsson ^a,g   Elgue, Graciela ^a   Korsgren, Olle ^a   Nilsson, Bo ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e University Hospital   (Sweden)

^f UNIVERSITY OF HELSINKI   (Finland)

^g LINNAEUS UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING FACTOR 8A; C PEPTIDE; GLUCAGON; INSULIN; MONOCLONAL ANTIBODY; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN;

ADULT; ALTERNATIVE RNA SPLICING; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; ENDOCRINE CELL; FEMALE; GENE TARGETING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; MALE; MEMBRANE BINDING; OUTCOMES RESEARCH; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ALTERNATIVE SPLICING; ANTITHROMBIN III; FACTOR VIIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; THROMBOPLASTIN; TIME FACTORS;

EID: 20044371024     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.6.1755     Document Type: Article

References (25)

1. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238, 2000
2. Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, Imes S, Rabinovitch A, Elliott JF, Bigam D, Kneteman NM, Warnock GL, Larsen I, Shapiro AM: Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50:710-719, 2001
3. Moberg L, Johansson H, Lukinius A, Berne C, Foss A, Källen R, Østraat Ø, Salmela K, Tibell A, Tufveson G, Elgue G, Nilsson Ekdahl K, Korsgren O, Nilsson B: Production of tissue factor by pancreatic islet cells triggers thrombotic reactions detrimental in clinical islet transplantation. Lancet 360:2039-2045, 2002
4. Bennet W, Sundberg B, Groth CG, Brendel MD, Brandhorst D, Brandhorst H, Bretzel RG, Elgue G, Larsson R, Nilsson B, Korsgren O: Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 48: 1907-1914, 1999
5. Moberg L, Olsson A, Berne C, Felldin M, Foss A, Kallen R, Salmela K, Tibell A, Tufveson G, Nilsson B, Korsgren O: Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation. Transplantation 76:1285-1288, 2003
6. Johansson U, Olsson A, Gabrielsson S, Nilsson B, Korsgren O: Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. Biochem Biophys Res Commun 308:474-479, 2003
7. Piemonti L, Leone BE, Nano R, Saccani A, Monti P, Maffi P, Bianchi G, Sica A, Peri G, Melzi R, Aldrighetti L, Secchi A, Di Carlo V, Allavena P, Bertuzzi F: Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes 51:55-65, 2002
8. Waeber G, Calandra T, Roduit R, Haefliger JA, Bonny C, Thompson N, Thorens B, Temler E, Meinhardt A, Bacher M, Metz CN, Nicod P, Bucala R: Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Acad Sci U S A 94:4782-4787, 1997
9. Brandhorst H, Brandhorst D, Brendel MD, Hering BJ, Bretzel RG: Assessment of intracellular insulin content during all steps of human islet isolation procedure. Cell Transplant 7:489-495, 1998
10. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW: Automated method for isolation of human pancreatic islets. Diabetes 37:413-420, 1988
11. Lakey JR, Warnock GL, Shapiro AM, Korbutt GS, Ao Z, Kneteman NM, Rajotte RV: Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant 8:285-292, 1999
12. Ozmen L, Ekdahl KN, Elgue G, Larsson R, Korsgren O, Nilsson B: Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes 51:1779-1784, 2002
13. Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y: Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 9:458-462, 2003
14. Lukinius A, Ericsson JL, Grimelius L, Korsgren O: Ultrastructural studies of the ontogeny of fetal human and porcine endocrine pancreas, with special reference to colocalization of the four major islet hormones. Dev Biol 153:376-385, 1992
15. Lukinius A, Korsgren O: The transplanted fetal endocrine pancreas undergoes an inherent sequential differentiation similar to that in the native pancreas: an ultrastructural study in the pig-to-mouse model. Diabetes 50:962-971, 2001
16. Nilsson Ekdahl K, Nilsson B, Pekna M, Nilsson UR: Generation of iC3 at the interface between blood and gas. Scand J Immunol 35:85-91, 1992
17. Gough NM: Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. Anal Biochem 173:93-95, 1988
18. Mavrommatis AC, Theodoridis T, Orfanidou A, Roussos C, Christopoulou-Kokkinou V, Zakynthinos S: Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med 28:451-457, 2000
19. Bjorquist P, Bostrom S: Determination of the kinetic constants of tissue factor/factor VII/factor VIIA and antithrombin/heparin using surface plasmon resonance. Thromb Res 85:225-236, 1997
20. Lormeau JC, Herault JP, Herbert JM: Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin. Thromb Haemost 76:5-8, 1996
21. Rao LV, Nordfang O, Hoang AD, Pendurthi UR: Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces: comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/tissue factor activity. Blood 85:121-129, 1995
22. Pileggi A, Ricordi C, Alessiani M, Inverardi L: Factors influencing Islet of Langerhans graft function and monitoring. Clin Chim Acta 310:3-16, 2001
23. Weitz JI, Crowther MA: New anticoagulants: current status and future potential. Am J Cardiovasc Drugs 3:201-209, 2003
24. Bretzel RG, Brendel M, Eckhard M, Brandhorst D, Jaeger C, Hatziagelaki E, Federlin K: Islet transplantation: present clinical situation and future aspects. Exp Clin Endocrinol Diabetes 109 (Suppl. 2):S384-S399, 2001
25. Chan RK, Ibrahim SI, Verna N, Carroll M, Moore FD Jr, Hechtman HB: Ischaemia-reperfusion is an event triggered by immune complexes and complement. Br J Surg 90:1470-1478, 2003